Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Sulesomab
ANSTO t/a ANSTO Health
Medicine Registered
LEUKOSCAN ® SULESOMAB 1 CONSUMER MEDICINE INFORMATION LEUKOSCAN ® SULESOMAB KIT FOR THE PREPARATION OF TECHNETIUM -99M LABELLED LEUKOSCAN WHAT IS IN THIS LEAFLET This leaflet answers some common questions about LeukoScan. It does not contain all the available information, nor does it take the place of you talking to your nuclear medicine specialist or physician. All medicines and diagnostic agents have risks and benefits associated with their use. Your nuclear medicine specialist has weighed the risks of you being treated with LeukoScan against the benefits it is expected you will receive. KEEP THIS LEAFLET. You may need to read it again. NAME OF YOUR MEDICINE LeukoScan is the trade name of your medicine. Sulesomab is the common name. PRODUCT DESCRIPTION Each 3-ml vial (glass container) contains 0.31mg of active substance, sulesomab, as a powder for solution for injection. The other ingredients are stannous chloride, sodium chloride, sodium potassium tartrate, sodium acetate and sucrose. WHAT LEUKOSCAN IS AND WHAT IT IS USED FOR An antibody is a natural substance made by the body which binds foreign substances to help remove them from your body. You produce many difference kinds on antibodies. LeukoScan Sulesomab is a special kind of antibody which binds to the surface of certain kinds of blood cells called leukocytes. It is produced in mice and purified so that if can be used in humans. When it is combined to the radioactive technetium isotope and injected, it finds an abnormal accumulation of white blood cells and attaches to them. This helps your do Read the complete document
_PI_ P RODUCT I NFORMATION Sterile, Non-pyrogenic, Lyophilized Powder for Intravenous Use after Reconstitution with Pertechnetate [ 99m Tc] Radiodiagnostic Agent, Infectious Disease Imaging Agent _PI_ P RODUCT I NFORMATION LEUKOSCAN ® , SULESOMAB KIT FOR THE PREPARATION OF TECHNETIUM-99M LABELLED LEUKOSCAN Immunomedics, Inc. 300 American Road Morris Plains, New Jersey 07950 United States of America Distributed by TGA Approval date: 5 March 2002 TGA Approval Date: 5th March 2002 AUST R: 82071 Product No: 10165 SUPPLIER LeukoScan is supplied in Australia by: LEUKOSCAN ® , SULESOMAB Locked Bag 2001 Kirrawee DC NSW 2232 Amended format: February 2011 Date of printing: 30/3/2011 ANSTO Health Locked Bag 2001 Kirrawee DC NSW 2232 Telephone: 1800 251 572 Facsimile: 02 9543 6511 ANSTO Health is a commercial enterprise of the Australian Nuclear Science and Technology Organisation (ANSTO), which is located at Lucas Heights, in Sydney, N.S.W. ANSTO Health 2. Table 1 Summary of Normal organ Dosimetry to an Average Adult Patient (70 kg) from an Intravenous Dose of Technetium-99m LeukoScan [Dose estimate from 13 Subjects 26 Administrations] AVERAGE DOSE ORGAN (ΜGY/MBQ) Kidneys Urinary Bladder Wall Spleen Heart Wall Lungs Liver Bone Surfaces Adrenals Red Marrow Pancreas Thyroid Gall Bladder Wall Uterus ovaries Small Intestine Stomach Upper Large Intestinal Wall Lower Large Intestinal Wall Thymus Total Body Muscle Testes Breasts Brain Skin effective Dose (µSv/MBq) PRESENTATION Package containing one (1) vial, with a single-use dose of 0.31 mg lyophilized sulesomab. The product should not be used beyond the expiration date printed on the label. EXPIRY The expiry date for this kit stored at 2°C-8°C is 48 months from the day of manufacture. STORAGE Store at 2°C-8°C. Do not freeze. To reduce microbiological hazard, Read the complete document